Search
Now showing items 1-10 of 10
Do androgens modulate luteinizing hormone secretion in women? ¿Modulan los andrógenos la secreción de hormona luteinizante en mujeres?
(1997)
In hyperandrogenic states an abnormal pattern of LH secretion in women is observed, which is presumed to result from a direct action of androgen or its conversion to estrogen. Two strategies are available to study the ...
Influence of size and duration of gynecomastia on its response to treatment with tamoxifen Terapia médica de la ginecomastia con tamoxifeno. Influencia del volumen y duración de la ginecomastia en el resultado terapéutico
(2007)
Background: Gynecomastia is treated when it is painful, there are psychosocial repercussions or it does not revert in less tan two years. It is treated with the antiestrogenic drug tamoxifen, but there are doubts about its ...
Markers of epithelial-mesenchymal transition in an experimental breast cancer model induced by organophosphorous pesticides and estrogen (Review)
(Spandidos, 2020)
Breast cancer is a major health problem and accounted for 11.6% of all new cancer cases and 6.6% of all cancer deaths among women worldwide in 2018. However, its etiology has remained elusive. According to epidemiological ...
Estradiol increases IP3 by a nongenomic mechanism in the smooth muscle cells from the rat oviduct
(Bioscientifica Ltd., 2015)
Estradiol (E-2) accelerates egg transport by a nongenomic action, requiring activation of estrogen receptor ( ER) and successive cAMP and IP3 production in the rat oviduct. Furthermore, E-2 increases IP3 production in ...
The Flavonoid Agathisflavone from Poincianella pyramidalis Prevents Aminochrome Neurotoxicity
(Springer, 2020)
Flavonoids have been suggested to protect dopaminergic neurons in Parkinson’s disease based on studies that used exogenous
neurotoxins. In this study, we tested the protective ability of agathisflavone in SH-SY5Y cells ...
27- hydroxycholesterol reverses estradiol induced inhibition of platelet aggregation in postmenopausal women Efecto del 27- hidroxicolesterol en la acción antiplaquetaria de estradiol en mujeres postmenopáusicas
(Sociedad Medica de Santiago, 2016)
© 2016, Sociedad Medica de Santiago. All Rights Reserved. Background: The decline of estrogen levels increases cardiovascular risk in women. Platelets express estrogen receptors and 17β-estradiol- (E2) can produce a ...
Molecular mechanisms of androstenediol in the regulation of the proliferative process of human endometrial cells
(SAGE Publications Inc, 2017)
Proliferation in endometria of women with polycystic ovarian syndrome (PCOS) is increased, similar to the biosynthesis of androstenediol (estrogenic metabolite). As previously shown, in human endometrial cells, androstenediol ...
Estradiol increases IP3 by a nongenomic mechanism in the smooth muscle cells from the rat oviduct
(Bioscientifica Ltd., 2015)
Estradiol (E2) accelerates egg transport by a nongenomic action, requiring activation of estrogen receptor (ER) and successive cAMP and
IP3 production in the rat oviduct. Furthermore, E2 increases IP3 production in primary ...
Estradiol increases cAMP in the oviductal secretory cells through a nongenomic mechanism
(BioScientifica Ltd., 2014)
In the rat oviduct, estradiol (E2) accelerates egg transport by a nongenomic action that requires previous conversion of E2 to methoxyestrogens via catechol-O-methyltranferase (COMT) and activation of estrogen receptor ...
A non-genomic signaling pathway shut down by mating changes the estradiol-induced gene expression profile in the rat oviduct
(Society for Reproduction and Fertility, 2010)
Estradiol (E2) accelerates oviductal egg transport through intraoviductal non-genomic pathways in unmated rats and through genomic
pathways in mated rats. This shift in pathways has been designated as intracellular path ...